| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.04 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.042 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.9 |